Three months ended | Year ended | ||||||||||||||||||||||||||||||||||||||||||||||
(in millions, except per-share data) | 12/31/2024 | 12/31/2023 | Change(1) | 9/30/2024 | Change(1) | 12/31/2024 | 12/31/2023 | Change(1) | |||||||||||||||||||||||||||||||||||||||
U.S. GAAP basis | |||||||||||||||||||||||||||||||||||||||||||||||
Investment advisory fees | $ | 1,667.2 | $ | 1,435.9 | 16.1 | % | $ | 1,627.3 | 2.5 | % | $ | 6,399.7 | $ | 5,709.5 | 12.1 | % | |||||||||||||||||||||||||||||||
Performance-based advisory fees(2) | $ | 19.3 | $ | 25.3 | (23.7) | % | $ | 5.6 | n/m | $ | 59.3 | $ | 38.2 | 55.2 | % | ||||||||||||||||||||||||||||||||
Capital allocation-based income(3) | $ | (5.2) | $ | 40.2 | n/m | $ | 4.6 | n/m | $ | 46.6 | $ | 161.9 | (71.2) | % | |||||||||||||||||||||||||||||||||
Net revenues | $ | 1,824.5 | $ | 1,642.0 | 11.1 | % | $ | 1,785.6 | 2.2 | % | $ | 7,093.6 | $ | 6,460.5 | 9.8 | % | |||||||||||||||||||||||||||||||
Operating expenses | $ | 1,256.1 | $ | 1,254.8 | 0.1 | % | $ | 1,172.0 | 7.2 | % | $ | 4,760.3 | $ | 4,474.3 | 6.4 | % | |||||||||||||||||||||||||||||||
Net operating income | $ | 568.4 | $ | 387.2 | 46.8 | % | $ | 613.6 | (7.4) | % | $ | 2,333.3 | $ | 1,986.2 | 17.5 | % | |||||||||||||||||||||||||||||||
Non-operating income (loss) | $ | 4.6 | $ | 259.7 | n/m | $ | 212.5 | n/m | $ | 486.3 | $ | 504.1 | (3.5) | % | |||||||||||||||||||||||||||||||||
Net income - T. Rowe Price Group, Inc. | $ | 439.9 | $ | 437.6 | 0.5 | % | $ | 603.0 | (27.0) | % | $ | 2,100.1 | $ | 1,788.7 | 17.4 | % | |||||||||||||||||||||||||||||||
Diluted earnings per common share | $ | 1.92 | $ | 1.90 | 1.1 | % | $ | 2.64 | (27.3) | % | $ | 9.15 | $ | 7.76 | 17.9 | % | |||||||||||||||||||||||||||||||
Adjusted basis(4) | |||||||||||||||||||||||||||||||||||||||||||||||
Operating expenses | $ | 1,222.6 | $ | 1,150.7 | 6.2 | % | $ | 1,099.0 | 11.2 | % | $ | 4,498.8 | $ | 4,260.7 | 5.6 | % | |||||||||||||||||||||||||||||||
Operating expenses, excluding accrued carried interest related compensation | $ | 1,218.7 | $ | 1,135.5 | 7.3 | % | $ | 1,087.4 | 12.1 | % | $ | 4,456.3 | $ | 4,190.7 | 6.3 | % | |||||||||||||||||||||||||||||||
Net operating income | $ | 620.2 | $ | 502.7 | 23.4 | % | $ | 718.4 | (13.7) | % | $ | 2,685.9 | $ | 2,263.2 | 18.7 | % | |||||||||||||||||||||||||||||||
Non-operating income (loss) | $ | 34.3 | $ | 49.5 | (30.7) | % | $ | 51.2 | (33.0) | % | $ | 148.7 | $ | 140.8 | 5.6 | % | |||||||||||||||||||||||||||||||
Net income - T. Rowe Price Group, Inc. | $ | 484.8 | $ | 394.7 | 22.8 | % | $ | 586.5 | (17.3) | % | $ | 2,139.5 | $ | 1,750.1 | 22.3 | % | |||||||||||||||||||||||||||||||
Diluted earnings per common share | $ | 2.12 | $ | 1.72 | 23.3 | % | $ | 2.57 | (17.5) | % | $ | 9.33 | $ | 7.59 | 22.9 | % | |||||||||||||||||||||||||||||||
Assets under management (in billions) | |||||||||||||||||||||||||||||||||||||||||||||||
Average assets under management | $ | 1,638.6 | $ | 1,374.3 | 19.2 | % | $ | 1,589.5 | 3.1 | % | $ | 1,561.9 | $ | 1,362.3 | 14.7 | % | |||||||||||||||||||||||||||||||
Ending assets under management | $ | 1,606.6 | $ | 1,444.5 | 11.2 | % | $ | 1,630.9 | (1.5) | % | $ | 1,606.6 | $ | 1,444.5 | 11.2 | % | |||||||||||||||||||||||||||||||
Investment advisory annualized effective fee rate (EFR) (in bps) | |||||||||||||||||||||||||||||||||||||||||||||||
EFR without performance-based fees | 40.5 | 41.5 | (1.0) | 40.7 | (0.2) | 41.0 | 41.9 | (0.9) | |||||||||||||||||||||||||||||||||||||||
EFR with performance-based fees | 40.9 | 42.2 | (1.3) | 40.9 | — | 41.4 | 42.2 | (0.8) |
Three months ended 12/31/2024 | |||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 832.0 | $ | 186.3 | $ | 560.9 | $ | 51.7 | $ | 1,630.9 | |||||||||||||||||||
Net cash flows prior to manager-driven distributions | (8.2) | 3.5 | (15.5) | 1.7 | (18.5) | ||||||||||||||||||||||||
Manager-driven distributions | — | — | — | (0.8) | (0.8) | ||||||||||||||||||||||||
Net cash flows | (8.2) | 3.5 | (15.5) | 0.9 | (19.3) | ||||||||||||||||||||||||
Net market appreciation (depreciation) and income(3) | 5.9 | (1.7) | (9.4) | 0.2 | (5.0) | ||||||||||||||||||||||||
Change during the period | (2.3) | 1.8 | (24.9) | 1.1 | (24.3) | ||||||||||||||||||||||||
Assets under management at December 31, 2024 | $ | 829.7 | $ | 188.1 | $ | 536.0 | $ | 52.8 | $ | 1,606.6 |
Three months ended | |||||||||||||||||||||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | Change | 9/30/2024 | Change | ||||||||||||||||||||||||
Investment advisory fees | |||||||||||||||||||||||||||||
Equity | $ | 1,006.2 | $ | 864.3 | 16.4 | % | $ | 978.5 | 2.8 | % | |||||||||||||||||||
Fixed income, including money market | 106.2 | 98.2 | 8.1 | % | 104.1 | 2.0 | % | ||||||||||||||||||||||
Multi-asset | 473.8 | 400.6 | 18.3 | % | 465.8 | 1.7 | % | ||||||||||||||||||||||
Alternatives | 81.0 | 72.8 | 11.3 | % | 78.9 | 2.7 | % | ||||||||||||||||||||||
Total investment advisory fees | 1,667.2 | 1,435.9 | 16.1 | % | 1,627.3 | 2.5 | % | ||||||||||||||||||||||
Performance-based advisory fees(1) | 19.3 | 25.3 | n/m | 5.6 | n/m | ||||||||||||||||||||||||
Capital allocation-based income(2) | (5.2) | 40.2 | n/m | 4.6 | n/m | ||||||||||||||||||||||||
Administrative, distribution, and servicing fees | 143.2 | 140.6 | 1.8 | % | 148.1 | (3.3) | % | ||||||||||||||||||||||
Net revenues | $ | 1,824.5 | $ | 1,642.0 | 11.1 | % | $ | 1,785.6 | 2.2 | % | |||||||||||||||||||
Average AUM (in billions): | |||||||||||||||||||||||||||||
Equity | $ | 842.7 | $ | 704.9 | 19.5 | % | $ | 813.1 | 3.6 | % | |||||||||||||||||||
Fixed income, including money market | 186.9 | 168.4 | 11.0 | % | 183.3 | 2.0 | % | ||||||||||||||||||||||
Multi-asset | 556.3 | 453.6 | 22.6 | % | 542.3 | 2.6 | % | ||||||||||||||||||||||
Alternatives | 52.7 | 47.4 | 11.2 | % | 50.8 | 3.7 | % | ||||||||||||||||||||||
Average AUM | $ | 1,638.6 | $ | 1,374.3 | 19.2 | % | $ | 1,589.5 | 3.1 | % | |||||||||||||||||||
Investment advisory annualized effective fee rate (bps) | 40.5 | 41.5 | (1.0) | 40.7 | (0.2) | ||||||||||||||||||||||||
Investment advisory annualized effective fee rate, including performance-based fees (bps) | 40.9 | 42.2 | (1.3) | 40.9 | — | ||||||||||||||||||||||||
Three months ended | |||||||||||||||||||||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | Change (1) | 9/30/2024 | Change (1) | ||||||||||||||||||||||||
Compensation, benefits, and related costs | $ | 705.4 | $ | 649.4 | 8.6 | % | $ | 632.9 | 11.5 | % | |||||||||||||||||||
Acquisition-related retention agreements | 14.2 | 13.5 | 5.2 | % | 4.0 | 255.0 | % | ||||||||||||||||||||||
Capital allocation-based income compensation(2) | (3.4) | 10.6 | n/m | (2.0) | n/m | ||||||||||||||||||||||||
Market-related change in deferred compensation liability | (6.7) | 61.9 | n/m | 43.4 | n/m | ||||||||||||||||||||||||
Total compensation and related costs | 709.5 | 735.4 | (3.5) | % | 678.3 | 4.6 | % | ||||||||||||||||||||||
Distribution and servicing | 92.9 | 75.7 | 22.7 | % | 91.6 | 1.4 | % | ||||||||||||||||||||||
Advertising and promotion | 50.2 | 44.4 | 13.1 | % | 20.8 | 141.3 | % | ||||||||||||||||||||||
Product and recordkeeping related costs | 74.5 | 68.1 | 9.4 | % | 75.0 | (0.7) | % | ||||||||||||||||||||||
Technology, occupancy, and facility costs | 169.3 | 171.6 | (1.3) | % | 164.0 | 3.2 | % | ||||||||||||||||||||||
General, administrative, and other | 128.3 | 128.1 | 0.2 | % | 104.2 | 23.1 | % | ||||||||||||||||||||||
Change in fair value of contingent consideration | — | (9.6) | n/m | (13.4) | n/m | ||||||||||||||||||||||||
Acquisition-related amortization and impairment costs | 31.4 | 41.1 | (23.6) | % | 51.5 | (39.0) | % | ||||||||||||||||||||||
Total operating expenses | $ | 1,256.1 | $ | 1,254.8 | 0.1 | % | $ | 1,172.0 | 7.2 | % | |||||||||||||||||||
Total adjusted operating expenses(3) | $ | 1,222.6 | $ | 1,150.7 | 6.2 | % | $ | 1,099.0 | 11.2 | % | |||||||||||||||||||
(in millions) | Three months ended | ||||||||||||||||
12/31/2024 | 12/31/2023 | 9/30/2024 | |||||||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||||||||
Cash and discretionary investments | |||||||||||||||||
Dividend income | $ | 39.8 | $ | 33.1 | $ | 37.4 | |||||||||||
Market-related gains (losses) and equity in earnings (losses) | (1.4) | 5.4 | 5.9 | ||||||||||||||
Total net gains (losses) from cash and discretionary investments | 38.4 | 38.5 | 43.3 | ||||||||||||||
Seed capital investments | |||||||||||||||||
Dividend income | 1.6 | 0.6 | 0.5 | ||||||||||||||
Market-related gains (losses) and equity in earnings (losses) | 1.9 | 25.3 | 21.3 | ||||||||||||||
Net gains (losses) recognized upon deconsolidation | 0.2 | (0.7) | (0.6) | ||||||||||||||
Investments used to hedge deferred compensation liabilities | (9.2) | 65.0 | 41.1 | ||||||||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 32.9 | 128.7 | 105.6 | ||||||||||||||
Other investment income (loss) | 11.8 | 12.8 | 13.4 | ||||||||||||||
Net gains (losses) on investments | 44.7 | 141.5 | 119.0 | ||||||||||||||
Net gains (losses) on consolidated investment products | (36.4) | 119.2 | 85.9 | ||||||||||||||
Other gains (losses), including foreign currency gains (losses) | (3.7) | (1.0) | 7.6 | ||||||||||||||
Non-operating income (loss) | $ | 4.6 | $ | 259.7 | $ | 212.5 | |||||||||||
Adjusted non-operating income (loss)(1) | $ | 34.3 | $ | 49.5 | $ | 51.2 | |||||||||||
Year ended | |||||||||||
12/31/2024 | 12/31/2023 | ||||||||||
Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | |||||||
State income taxes for current year, net of federal income tax benefits(1) | 2.9 | 2.3 | |||||||||
Net (income) losses attributable to redeemable non-controlling interests(2) | (0.3) | (0.5) | |||||||||
Net excess tax losses (benefits) from stock-based compensation plans activity | (0.2) | 0.1 | |||||||||
Valuation allowances | 0.2 | 3.4 | |||||||||
Other items | 0.7 | — | |||||||||
Effective income tax rate | 24.3 | % | 26.3 | % | |||||||
Public Relations | Investor Relations | ||||||||||
Jamaal Mobley | Linsley Carruth | ||||||||||
410-345-3403 | 410-345-3717 | ||||||||||
jamaal.mobley@troweprice.com | linsley.carruth@troweprice.com | ||||||||||
Unaudited Consolidated Statements of Income | |||||||||||||||||||||||||||||||||||
(in millions, except per-share amounts) | |||||||||||||||||||||||||||||||||||
Three months ended | Year ended | ||||||||||||||||||||||||||||||||||
Revenues | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||||||||
Investment advisory fees | $ | 1,667.2 | $ | 1,435.9 | $ | 1,627.3 | $ | 6,399.7 | $ | 5,709.5 | |||||||||||||||||||||||||
Performance-based advisory fees(1) | 19.3 | 25.3 | 5.6 | 59.3 | 38.2 | ||||||||||||||||||||||||||||||
Capital allocation-based income | (5.2) | 40.2 | 4.6 | 46.6 | 161.9 | ||||||||||||||||||||||||||||||
Administrative, distribution, and servicing fees | 143.2 | 140.6 | 148.1 | 588.0 | 550.9 | ||||||||||||||||||||||||||||||
Net revenues | 1,824.5 | 1,642.0 | 1,785.6 | 7,093.6 | 6,460.5 | ||||||||||||||||||||||||||||||
Operating expenses | |||||||||||||||||||||||||||||||||||
Compensation, benefits, and related costs | 705.4 | 649.4 | 632.9 | 2,603.4 | 2,450.7 | ||||||||||||||||||||||||||||||
Acquisition-related retention agreements | 14.2 | 13.5 | 4.0 | 44.8 | 55.0 | ||||||||||||||||||||||||||||||
Capital allocation-based income compensation | (3.4) | 10.6 | (2.0) | 5.4 | 44.6 | ||||||||||||||||||||||||||||||
Market-related change in deferred compensation liabilities | (6.7) | 61.9 | 43.4 | 104.3 | 123.2 | ||||||||||||||||||||||||||||||
Total compensation and related costs | 709.5 | 735.4 | 678.3 | 2,757.9 | 2,673.5 | ||||||||||||||||||||||||||||||
Distribution and servicing | 92.9 | 75.7 | 91.6 | 354.1 | 289.9 | ||||||||||||||||||||||||||||||
Advertising and promotion | 50.2 | 44.4 | 20.8 | 129.6 | 114.2 | ||||||||||||||||||||||||||||||
Product and recordkeeping related costs | 74.5 | 68.1 | 75.0 | 297.5 | 291.0 | ||||||||||||||||||||||||||||||
Technology, occupancy, and facility costs | 169.3 | 171.6 | 164.0 | 644.1 | 632.6 | ||||||||||||||||||||||||||||||
General, administrative, and other | 128.3 | 128.1 | 104.2 | 433.8 | 421.3 | ||||||||||||||||||||||||||||||
Change in fair value of contingent consideration | — | (9.6) | (13.4) | (13.4) | (82.4) | ||||||||||||||||||||||||||||||
Acquisition-related amortization and impairment costs | 31.4 | 41.1 | 51.5 | 156.7 | 134.2 | ||||||||||||||||||||||||||||||
Total operating expenses | 1,256.1 | 1,254.8 | 1,172.0 | 4,760.3 | 4,474.3 | ||||||||||||||||||||||||||||||
Net operating income | 568.4 | 387.2 | 613.6 | 2,333.3 | 1,986.2 | ||||||||||||||||||||||||||||||
Non-operating income (loss) | |||||||||||||||||||||||||||||||||||
Net gains (losses) on investments | 44.7 | 141.5 | 119.0 | 363.2 | 355.2 | ||||||||||||||||||||||||||||||
Net gains (losses) on consolidated investment products | (36.4) | 119.2 | 85.9 | 130.3 | 164.6 | ||||||||||||||||||||||||||||||
Other gains (losses), including foreign currency gains (losses) | (3.7) | (1.0) | 7.6 | (7.2) | (15.7) | ||||||||||||||||||||||||||||||
Total non-operating income (loss) | 4.6 | 259.7 | 212.5 | 486.3 | 504.1 | ||||||||||||||||||||||||||||||
Income before income taxes | 573.0 | 646.9 | 826.1 | 2,819.6 | 2,490.3 | ||||||||||||||||||||||||||||||
Provision for income taxes | 156.3 | 173.3 | 185.7 | 683.8 | 654.6 | ||||||||||||||||||||||||||||||
Net income | 416.7 | 473.6 | 640.4 | 2,135.8 | 1,835.7 | ||||||||||||||||||||||||||||||
Less: net income (loss) attributable to redeemable non-controlling interests | (23.2) | 36.0 | 37.4 | 35.7 | 47.0 | ||||||||||||||||||||||||||||||
Net income attributable to T. Rowe Price Group, Inc. | 439.9 | 437.6 | 603.0 | 2,100.1 | 1,788.7 | ||||||||||||||||||||||||||||||
Less: net income allocated to outstanding restricted stock and stock unit holders | 11.6 | 11.7 | 15.5 | 55.8 | 44.4 | ||||||||||||||||||||||||||||||
Net income allocated to T. Rowe Price common stockholders | $ | 428.3 | $ | 425.9 | $ | 587.5 | $ | 2,044.3 | $ | 1,744.3 | |||||||||||||||||||||||||
Earnings per share | |||||||||||||||||||||||||||||||||||
Basic | $ | 1.93 | $ | 1.91 | $ | 2.64 | $ | 9.18 | $ | 7.78 | |||||||||||||||||||||||||
Diluted | $ | 1.92 | $ | 1.90 | $ | 2.64 | $ | 9.15 | $ | 7.76 | |||||||||||||||||||||||||
Weighted-average common shares | |||||||||||||||||||||||||||||||||||
Outstanding | 222.4 | 223.5 | 222.3 | 222.8 | 224.1 | ||||||||||||||||||||||||||||||
Outstanding assuming dilution | 222.8 | 224.0 | 222.8 | 223.3 | 224.8 | ||||||||||||||||||||||||||||||
Summary of Adjusted Basis(2) | Three months ended | Year ended | |||||||||||||||||||||||||||||||||
(in millions, except per-share data) | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||||||||
Operating expenses | $ | 1,222.6 | $ | 1,150.7 | $ | 1,099.0 | $ | 4,498.8 | $ | 4,260.7 | |||||||||||||||||||||||||
Operating expenses, excluding accrued carried interest related compensation | $ | 1,218.7 | $ | 1,135.5 | $ | 1,087.4 | $ | 4,456.3 | $ | 4,190.7 | |||||||||||||||||||||||||
Net operating income | $ | 620.2 | $ | 502.7 | $ | 718.4 | $ | 2,685.9 | $ | 2,263.2 | |||||||||||||||||||||||||
Non-operating income (loss) | $ | 34.3 | $ | 49.5 | $ | 51.2 | $ | 148.7 | $ | 140.8 | |||||||||||||||||||||||||
Net income attributable to T. Rowe Price | $ | 484.8 | $ | 394.7 | $ | 586.5 | $ | 2,139.5 | $ | 1,750.1 | |||||||||||||||||||||||||
Diluted earnings per common share | $ | 2.12 | $ | 1.72 | $ | 2.57 | $ | 9.33 | $ | 7.59 |
Assets Under Management | Year ended 12/31/2024 | ||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Alternatives(2) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 743.6 | $ | 170.0 | $ | 483.0 | $ | 47.9 | $ | 1,444.5 | |||||||||||||||||||
Net cash flows prior to manager-driven distributions | (52.0) | 12.6 | (6.5) | 6.4 | (39.5) | ||||||||||||||||||||||||
Manager-driven distributions | — | — | — | (3.7) | (3.7) | ||||||||||||||||||||||||
Net cash flows | (52.0) | 12.6 | (6.5) | 2.7 | (43.2) | ||||||||||||||||||||||||
Net market appreciation and gains(3) | 138.1 | 5.5 | 59.5 | 2.2 | 205.3 | ||||||||||||||||||||||||
Change during the period | 86.1 | 18.1 | 53.0 | 4.9 | 162.1 | ||||||||||||||||||||||||
Assets under management at December 31, 2024 | $ | 829.7 | $ | 188.1 | $ | 536.0 | $ | 52.8 | $ | 1,606.6 |
Net Revenues | Year ended | ||||||||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | % Change | ||||||||||||||
Investment advisory fees | |||||||||||||||||
Equity | $ | 3,864.7 | $ | 3,442.3 | 12.3 | % | |||||||||||
Fixed income, including money market | 410.7 | 400.4 | 2.6 | % | |||||||||||||
Multi-asset | 1,814.1 | 1,583.4 | 14.6 | % | |||||||||||||
Alternatives | 310.2 | 283.4 | 9.5 | % | |||||||||||||
Total investment advisory fees | $ | 6,399.7 | $ | 5,709.5 | 12.1 | % | |||||||||||
Average AUM (in billions): | |||||||||||||||||
Equity | $ | 804.3 | $ | 705.2 | 14.1 | % | |||||||||||
Fixed income, including money market | 178.6 | 169.3 | 5.5 | % | |||||||||||||
Multi-asset | 529.0 | 442.3 | 19.6 | % | |||||||||||||
Alternatives | 50.0 | 45.5 | 9.9 | % | |||||||||||||
Average AUM | $ | 1,561.9 | $ | 1,362.3 | 14.7 | % | |||||||||||
Non-Operating Income (Loss) | Year ended | ||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | |||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||||||
Cash and discretionary investments | |||||||||||
Dividend income | $ | 138.6 | $ | 109.1 | |||||||
Market-related gains (losses) and equity in earnings (losses) | 4.8 | 24.5 | |||||||||
Total net gains (losses) from cash and discretionary investments | 143.4 | 133.6 | |||||||||
Seed capital investments | |||||||||||
Dividend income | 2.4 | 1.8 | |||||||||
Market-related gains (losses) and equity in earnings (losses) | 62.0 | 50.3 | |||||||||
Net gains (losses) recognized upon deconsolidation | (0.4) | — | |||||||||
Investments used to hedge deferred compensation liabilities | 96.4 | 123.6 | |||||||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | 303.8 | 309.3 | |||||||||
Other investment income (loss) | 59.4 | 45.9 | |||||||||
Net gains (losses) on investments | 363.2 | 355.2 | |||||||||
Net gains (losses) on consolidated investment portfolios | 130.3 | 164.6 | |||||||||
Other gains (losses), including foreign currency gains (losses) | (7.2) | (15.7) | |||||||||
Non-operating income (loss) | $ | 486.3 | $ | 504.1 | |||||||
Adjusted non-operating income (loss)(1) | $ | 148.7 | $ | 140.8 | |||||||
Year ended | |||||||||||||||||||||||
12/31/2024 | |||||||||||||||||||||||
(in millions) | Cash flow attributable to T. Rowe Price | Cash flow attributable to consolidated investment products | Elims | As reported | |||||||||||||||||||
Cash flows from operating activities | |||||||||||||||||||||||
Net income (loss) | $ | 2,100.1 | $ | 120.5 | $ | (84.8) | $ | 2,135.8 | |||||||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||||||||||||||||||||
Depreciation, amortization and impairments of property, equipment and software | 254.1 | — | — | 254.1 | |||||||||||||||||||
Amortization and impairment of acquisition-related assets and retention agreements | 250.1 | — | — | 250.1 | |||||||||||||||||||
Fair value remeasurement of contingent liability | (13.4) | — | — | (13.4) | |||||||||||||||||||
Stock-based compensation expense | 247.3 | — | — | 247.3 | |||||||||||||||||||
Net (gains) losses recognized on investments | (425.0) | — | 84.8 | (340.2) | |||||||||||||||||||
Net investments in investment products used to economically hedge deferred compensation liabilities | (123.2) | — | 30.0 | (93.2) | |||||||||||||||||||
Net change in trading securities held by consolidated investment products | — | (760.4) | — | (760.4) | |||||||||||||||||||
Other changes | 23.9 | 6.1 | (24.5) | 5.5 | |||||||||||||||||||
Net cash provided by (used in) operating activities | 2,313.9 | (633.8) | 5.5 | 1,685.6 | |||||||||||||||||||
Net cash provided by (used in) investing activities | (187.9) | (15.8) | 26.2 | (177.5) | |||||||||||||||||||
Net cash provided by (used in) financing activities | (1,542.8) | 637.9 | (31.7) | (936.6) | |||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents of consolidated investment products | — | (2.4) | — | (2.4) | |||||||||||||||||||
Net change in cash and cash equivalents during year | 583.2 | (14.1) | — | 569.1 | |||||||||||||||||||
Cash and cash equivalents at beginning of year | 2,066.6 | 77.2 | — | 2,143.8 | |||||||||||||||||||
Cash and cash equivalents at end of year | $ | 2,649.8 | $ | 63.1 | $ | — | $ | 2,712.9 |
Unaudited Condensed Consolidated Balance Sheet Information | As of | ||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | |||||||||
Cash and cash equivalents | $ | 2,649.8 | $ | 2,066.6 | |||||||
Accounts receivable and accrued revenue | 877.4 | 807.9 | |||||||||
Investments | 3,000.5 | 2,554.7 | |||||||||
Assets of consolidated investment products | 2,044.0 | 1,959.3 | |||||||||
Operating lease assets | 226.8 | 241.1 | |||||||||
Property, equipment and software, net | 977.0 | 806.6 | |||||||||
Goodwill and intangible assets | 3,010.9 | 3,150.1 | |||||||||
Other assets | 685.6 | 692.5 | |||||||||
Total assets | 13,472.0 | 12,278.8 | |||||||||
Deferred compensation liabilities | 1,020.7 | 895.0 | |||||||||
Total other liabilities, includes $62.1 at December 31, 2024, and $54.2 at December 31, 2023, from consolidated investment products | 1,001.2 | 1,092.6 | |||||||||
Non-controlling interests* | 1,104.7 | 786.1 | |||||||||
Stockholders' equity attributable to T. Rowe Price Group, Inc., 223.0 common shares outstanding at December 31, 2024 and 223.9 common shares outstanding at December 31, 2023 | $ | 10,345.4 | $ | 9,505.1 |
Investments in affiliated private investment funds - carried interest | Three months ended | Year ended | |||||||||||||||||||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||
Balance at beginning of period | $ | 499.7 | $ | 578.2 | $ | 497.3 | $ | 519.9 | $ | 467.8 | |||||||||||||||||||
Capital allocation-based income: | |||||||||||||||||||||||||||||
Change in accrued carried interest | 12.5 | 51.1 | 35.1 | 134.1 | 223.2 | ||||||||||||||||||||||||
Acquisition-related amortization and impairments | (17.7) | (10.9) | (30.5) | (87.5) | (61.3) | ||||||||||||||||||||||||
Net distributions | (67.6) | (98.5) | (2.2) | (139.6) | (109.8) | ||||||||||||||||||||||||
Balance at end of period | $ | 426.9 | $ | 519.9 | $ | 499.7 | $ | 426.9 | $ | 519.9 |
Non-controlling interests (NCI) in consolidated entities | Three months ended | Year ended | |||||||||||||||||||||||||||
(in millions) | 12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | ||||||||||||||||||||||||
Balance at beginning of period | $ | 203.4 | $ | 221.5 | $ | 205.3 | $ | 192.0 | $ | 190.7 | |||||||||||||||||||
Capital allocation-based income compensation: | |||||||||||||||||||||||||||||
Change in accrued carried interest compensation | 3.9 | 15.2 | 11.6 | 42.5 | 70.0 | ||||||||||||||||||||||||
Acquisition-related amortization and impairments | (7.3) | (4.6) | (13.6) | (37.1) | (25.4) | ||||||||||||||||||||||||
Net contributions (distributions) | (39.3) | (40.1) | 0.1 | (36.7) | (43.3) | ||||||||||||||||||||||||
Balance at end of period | $ | 160.7 | $ | 192.0 | $ | 203.4 | $ | 160.7 | $ | 192.0 |
Three months ended 12/31/2024 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,256.1 | $ | 568.4 | $ | 4.6 | $ | 156.3 | $ | 439.9 | $ | 1.92 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 7.3 | 10.4 | — | 2.4 | 8.0 | 0.04 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (14.2) | 14.2 | — | 3.3 | 10.9 | 0.04 | |||||||||||||||||||||||||||||
Contingent consideration(1) | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (31.4) | 31.4 | — | 7.2 | 24.2 | 0.11 | |||||||||||||||||||||||||||||
Total acquisition-related | (38.3) | 56.0 | — | 12.9 | 43.1 | 0.19 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | 6.7 | (6.7) | 9.2 | 0.6 | 1.9 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (1.9) | 2.5 | 36.4 | 3.6 | 12.1 | 0.05 | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (15.9) | (3.7) | (12.2) | (0.05) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,222.6 | $ | 620.2 | $ | 34.3 | $ | 169.7 | $ | 484.8 | $ | 2.12 |
Three months ended 12/31/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,254.8 | $ | 387.2 | $ | 259.7 | $ | 173.3 | $ | 437.6 | $ | 1.90 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 4.6 | 6.3 | — | 1.7 | 4.6 | 0.02 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (13.5) | 13.5 | — | 3.6 | 9.9 | 0.04 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 9.6 | (9.6) | — | (2.6) | (7.0) | (0.03) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (41.1) | 41.1 | — | 11.1 | 30.0 | 0.14 | |||||||||||||||||||||||||||||
Total acquisition-related | (40.4) | 51.3 | — | 13.8 | 37.5 | 0.17 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | (61.9) | 61.9 | (65.0) | (0.8) | (2.3) | (0.01) | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (1.8) | 2.3 | (119.2) | (21.8) | (59.1) | (0.26) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (26.0) | (7.0) | (19.0) | (0.08) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,150.7 | $ | 502.7 | $ | 49.5 | $ | 157.5 | $ | 394.7 | $ | 1.72 |
Three months ended 9/30/2024 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 1,172.0 | $ | 613.6 | $ | 212.5 | $ | 185.7 | $ | 603.0 | $ | 2.64 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 13.6 | 16.9 | — | 2.3 | 14.6 | 0.06 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (4.0) | 4.0 | — | 0.5 | 3.5 | 0.02 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 13.4 | (13.4) | — | (1.8) | (11.6) | (0.05) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (51.5) | 51.5 | — | 7.0 | 44.5 | 0.19 | |||||||||||||||||||||||||||||
Total acquisition-related | (28.5) | 59.0 | — | 8.0 | 51.0 | 0.22 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | (43.4) | 43.4 | (41.1) | 0.3 | 2.0 | 0.01 | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (1.1) | 2.4 | (85.9) | (6.3) | (39.8) | (0.17) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (34.3) | (4.6) | (29.7) | (0.13) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 1,099.0 | $ | 718.4 | $ | 51.2 | $ | 183.1 | $ | 586.5 | $ | 2.57 |
Year ended 12/31/2024 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(5) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(6) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 4,760.3 | $ | 2,333.3 | $ | 486.3 | $ | 683.8 | $ | 2,100.1 | $ | 9.15 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 37.1 | 50.4 | — | 10.2 | 40.2 | 0.18 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (44.8) | 44.8 | — | 10.4 | 34.4 | 0.15 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 13.4 | (13.4) | — | (1.8) | (11.6) | (0.05) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (156.7) | 156.7 | — | 32.2 | 124.5 | 0.54 | |||||||||||||||||||||||||||||
Total acquisition-related | (151.0) | 238.5 | — | 51.0 | 187.5 | 0.82 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | (104.3) | 104.3 | (96.4) | 1.7 | 6.2 | 0.03 | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (6.2) | 9.8 | (130.3) | (17.5) | (67.3) | (0.29) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (110.9) | (23.9) | (87.0) | (0.38) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 4,498.8 | $ | 2,685.9 | $ | 148.7 | $ | 695.1 | $ | 2,139.5 | $ | 9.33 |
Year ended 12/31/2023 | |||||||||||||||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price Group, Inc. | Diluted earnings per share(7) | ||||||||||||||||||||||||||||||
U.S. GAAP Basis (FS line item) | $ | 4,474.3 | $ | 1,986.2 | $ | 504.1 | $ | 654.6 | $ | 1,788.7 | $ | 7.76 | |||||||||||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||||||||
Acquisition-related: | |||||||||||||||||||||||||||||||||||
Investment and NCI amortization and impairments(1) (Capital allocation-based income and Compensation and related costs) | 25.4 | 35.9 | — | 7.9 | 28.0 | 0.12 | |||||||||||||||||||||||||||||
Acquisition-related retention arrangements(1) (Compensation and related costs) | (55.0) | 55.0 | — | 10.8 | 44.2 | 0.19 | |||||||||||||||||||||||||||||
Contingent consideration(1) | 82.4 | (82.4) | — | (10.6) | (71.8) | (0.31) | |||||||||||||||||||||||||||||
Intangible assets amortization and impairments(1) | (134.2) | 134.2 | — | 28.8 | 105.4 | 0.46 | |||||||||||||||||||||||||||||
Total acquisition-related | (81.4) | 142.7 | — | 36.9 | 105.8 | 0.46 | |||||||||||||||||||||||||||||
Deferred compensation liabilities(2) (Compensation and related costs) | (123.2) | 123.2 | (123.6) | 0.5 | (0.9) | — | |||||||||||||||||||||||||||||
Consolidated investment products(3) | (9.0) | 11.1 | (164.6) | (22.3) | (84.2) | (0.37) | |||||||||||||||||||||||||||||
Other non-operating income(4) | — | — | (75.1) | (15.8) | (59.3) | (0.26) | |||||||||||||||||||||||||||||
Adjusted Non-GAAP Basis | $ | 4,260.7 | $ | 2,263.2 | $ | 140.8 | $ | 653.9 | $ | 1,750.1 | $ | 7.59 |
Three months ended | Year ended | ||||||||||||||||||||||||||||
12/31/2024 | 12/31/2023 | 9/30/2024 | 12/31/2024 | 12/31/2023 | |||||||||||||||||||||||||
Adjusted net income attributable to T. Rowe Price | $ | 484.8 | $ | 394.7 | $ | 586.5 | $ | 2,139.5 | $ | 1,750.1 | |||||||||||||||||||
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 12.7 | 10.6 | 15.0 | 56.8 | 43.4 | ||||||||||||||||||||||||
Adjusted net income allocated to common stockholders | $ | 472.1 | $ | 384.1 | $ | 571.5 | $ | 2,082.7 | $ | 1,706.7 |